Stockscreener 앱 받기
32.15
2.90%
-0.96
시장 영업 전:
32.15
Kiniksa Pharmaceuticals International Plc 주식(KNSA)의 최신 뉴스
Michael R. Megna Sells 17,000 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Stock - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) COO Sells $4,601,984.80 in Stock - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) CFO Sells $621,259.21 in Stock - MarketBeat
John F. Paolini Sells 29,325 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Stock - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Hits New 52-Week HighHere's What Happened - MarketBeat
BIT Capital GmbH Takes $264,000 Position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat
Kiniksa Pharmaceuticals International, plc (KNSA) Is Up 21.46% in One Week: What You Should Know - Yahoo Finance
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Upgraded at Wall Street Zen - Defense World
Wedbush Issues Positive Outlook for KNSA Earnings - MarketBeat
Kiniksa Pharmaceuticals surges 11.01% on Arcalyst's market penetration - AInvest
Victory Capital Management Inc. Makes New Investment in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat
Does Kiniksa Pharmaceuticals International, plc (KNSA) Have the Potential to Rally 35.96% as Wall Street Analysts Expect? - MSN
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 12-Month High After Earnings Beat - MarketBeat
Equities Analysts Set Expectations for KNSA Q3 Earnings - Defense World
Why Kiniksa Pharmaceuticals International, plc (KNSA) Might be Well Poised for a Surge - Yahoo Finance
Here's Why Momentum in Kiniksa Pharmaceuticals International, plc (KNSA) Should Keep going - Yahoo Finance
Victory Capital Management Inc. Takes $1.18 Million Position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World
Kiniksa Pharmaceuticals Achieves 52% YoY Growth in Q2 2025, Raises Revenue Guidance - AInvest
Kiniksa Pharmaceuticals International, plc (KNSA) Tops Q2 Earnings and Revenue Estimates - MSN
Kiniksa raises ARCALYST 2025 revenue guidance to $625M-$640M as patient penetration rises - MSN
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q2 2025 Earnings Call Transcript - Insider Monkey
Kiniksa Pharmaceuticals International Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Kiniksa Pharmaceuticals International PLC (KNSA) Q2 2025 Earnings Call Highlights: Record ... - Yahoo Finance
Analysts Set Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) PT at $39.67 - MarketBeat
Kiniksa Pharmaceuticals International PLC (KNSA) Q2 2025 Earnings Call Highlights: Record ... By GuruFocus - Investing.com Canada
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Hits New 1-Year High After Strong Earnings - Defense World
Kiniksa Pharmaceuticals Reports Strong Q2 2025 Growth - TipRanks
Kiniksa: Jefferies maintains Buy, raises PT to $54 from $45. - AInvest
Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution - GlobeNewswire
Kiniksa Pharmaceuticals Q2 2025 Earnings Call Transcript: Key Highlights and Financial Results - AInvest
Kiniksa Pharmaceuticals stock hits 52-week high at 30.8 USD By Investing.com - Investing.com Nigeria
Kiniksa Pharmaceuticals International Q2 2025 Earnings Call Transcript - MarketBeat
Kiniksa Pharmaceuticals Reports Q2 2025 Financial Results with 52% Growth in ARCALYST Revenue and Updates on Clinical Trials - Quiver Quantitative
Kiniksa Crushes Earnings: ARCALYST Sales Jump 52%, Company Raises 2025 Revenue Target to $640M - Stock Titan
Kiniksa Pharmaceuticals Q2 2025 Earnings Preview: $0.22 EPS, $145.21M Revenue Expected - AInvest
Cwm LLC Purchases 19,828 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of “Buy” by Analysts - Defense World
Kiniksa Pharmaceuticals Announces Q2 2025 Financial Results Conference Call. - AInvest
Kiniksa Pharmaceuticals International PLC expected to post earnings of 18 cents a shareEarnings Preview - TradingView
Cwm LLC Has $491,000 Holdings in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World
Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewswire
Kiniksa Pharmaceuticals Q2 2025 Earnings: Key Financial Results Coming July 29How to Join - Stock Titan
Cerity Partners LLC Boosts Stock Holdings in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World
Kiniksa Pharmaceuticals Ltd. Stock Analysis and ForecastExceptional gains - Autocar Professional
BlackRock, Inc. Significantly Reduces Holdings in Kiniksa Pharmaceuticals International PLC - GuruFocus
Kiniksa Pharmaceuticals International’s (KNSA) “Outperform” Rating Reaffirmed at Wedbush - Defense World
0.43%
0.47%
자본화:
|
볼륨(24시간):